AVXL
Price
$9.46
Change
+$0.06 (+0.64%)
Updated
Jun 26, 01:10 PM (EDT)
Capitalization
803.35M
47 days until earnings call
TRAW
Price
$1.41
Change
-$0.02 (-1.41%)
Updated
Jun 26, 01:21 PM (EDT)
Capitalization
7.9M
Interact to see
Advertisement

AVXL vs TRAW

Header iconAVXL vs TRAW Comparison
Open Charts AVXL vs TRAWBanner chart's image
Anavex Life Sciences
Price$9.46
Change+$0.06 (+0.64%)
Volume$200
Capitalization803.35M
Traws Pharma
Price$1.41
Change-$0.02 (-1.41%)
Volume$100
Capitalization7.9M
AVXL vs TRAW Comparison Chart in %
Loading...
AVXL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRAW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVXL vs. TRAW commentary
Jun 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVXL is a StrongBuy and TRAW is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 26, 2025
Stock price -- (AVXL: $9.41 vs. TRAW: $1.42)
Brand notoriety: AVXL and TRAW are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVXL: 105% vs. TRAW: 19%
Market capitalization -- AVXL: $803.35M vs. TRAW: $7.9M
AVXL [@Biotechnology] is valued at $803.35M. TRAW’s [@Biotechnology] market capitalization is $7.9M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.49B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVXL’s FA Score shows that 0 FA rating(s) are green whileTRAW’s FA Score has 1 green FA rating(s).

  • AVXL’s FA Score: 0 green, 5 red.
  • TRAW’s FA Score: 1 green, 4 red.
According to our system of comparison, both AVXL and TRAW are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVXL’s TA Score shows that 6 TA indicator(s) are bullish while TRAW’s TA Score has 3 bullish TA indicator(s).

  • AVXL’s TA Score: 6 bullish, 4 bearish.
  • TRAW’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, AVXL is a better buy in the short-term than TRAW.

Price Growth

AVXL (@Biotechnology) experienced а +4.21% price change this week, while TRAW (@Biotechnology) price change was -13.94% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.78%. For the same industry, the average monthly price growth was +31.36%, and the average quarterly price growth was +15.04%.

Reported Earning Dates

AVXL is expected to report earnings on Aug 12, 2025.

TRAW is expected to report earnings on Mar 31, 2025.

Industries' Descriptions

@Biotechnology (+1.78% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AVXL($803M) has a higher market cap than TRAW($7.9M). AVXL YTD gains are higher at: -12.384 vs. TRAW (-84.009). TRAW has higher annual earnings (EBITDA): -24.89M vs. AVXL (-45.65M). AVXL has more cash in the bank: 116M vs. TRAW (15.9M). TRAW has higher revenues than AVXL: TRAW (227K) vs AVXL (0).
AVXLTRAWAVXL / TRAW
Capitalization803M7.9M10,163%
EBITDA-45.65M-24.89M183%
Gain YTD-12.384-84.00915%
P/E RatioN/AN/A-
Revenue0227K-
Total Cash116M15.9M730%
Total Debt88.2KN/A-
FUNDAMENTALS RATINGS
AVXL vs TRAW: Fundamental Ratings
AVXL
TRAW
OUTLOOK RATING
1..100
2394
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
28
Undervalued
PROFIT vs RISK RATING
1..100
80100
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
3965
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TRAW's Valuation (28) in the Biotechnology industry is in the same range as AVXL (59). This means that TRAW’s stock grew similarly to AVXL’s over the last 12 months.

AVXL's Profit vs Risk Rating (80) in the Biotechnology industry is in the same range as TRAW (100). This means that AVXL’s stock grew similarly to TRAW’s over the last 12 months.

AVXL's SMR Rating (97) in the Biotechnology industry is in the same range as TRAW (100). This means that AVXL’s stock grew similarly to TRAW’s over the last 12 months.

AVXL's Price Growth Rating (39) in the Biotechnology industry is in the same range as TRAW (65). This means that AVXL’s stock grew similarly to TRAW’s over the last 12 months.

AVXL's P/E Growth Rating (100) in the Biotechnology industry is in the same range as TRAW (100). This means that AVXL’s stock grew similarly to TRAW’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AVXLTRAW
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 1 day ago
86%
Momentum
ODDS (%)
Bullish Trend 1 day ago
73%
Bearish Trend 1 day ago
87%
MACD
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
77%
Advances
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 17 days ago
76%
Declines
ODDS (%)
Bearish Trend about 1 month ago
81%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
AVXL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRAW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AACT11.30N/A
N/A
Ares Acquisition Corp
BEN23.21-0.02
-0.09%
Franklin Resources
FATE1.16-0.01
-0.85%
Fate Therapeutics
INAB2.18-0.06
-2.68%
IN8bio Inc
KOS1.86-0.08
-4.12%
Kosmos Energy Ltd

AVXL and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVXL has been loosely correlated with PLRX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if AVXL jumps, then PLRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVXL
1D Price
Change %
AVXL100%
-1.57%
PLRX - AVXL
48%
Loosely correlated
+6.15%
TENX - AVXL
47%
Loosely correlated
+6.11%
AXON - AVXL
45%
Loosely correlated
-1.16%
RXRX - AVXL
44%
Loosely correlated
-1.15%
VCYT - AVXL
41%
Loosely correlated
-1.60%
More

TRAW and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRAW has been loosely correlated with RAPT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if TRAW jumps, then RAPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRAW
1D Price
Change %
TRAW100%
-8.39%
RAPT - TRAW
46%
Loosely correlated
+16.30%
SLGL - TRAW
46%
Loosely correlated
+2.76%
MDGL - TRAW
39%
Loosely correlated
-2.58%
CYTK - TRAW
36%
Loosely correlated
-0.87%
AVXL - TRAW
35%
Loosely correlated
-1.57%
More